BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 32259702)

  • 1. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
    Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
    Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice.
    Selvakumar GP; Ahmed ME; Thangavel R; Kempuraj D; Dubova I; Raikwar SP; Zaheer S; Iyer SS; Zaheer A
    Brain Behav Immun; 2020 Jul; 87():429-443. PubMed ID: 31982500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.
    Kempuraj D; Selvakumar GP; Thangavel R; Ahmed ME; Zaheer S; Kumar KK; Yelam A; Kaur H; Dubova I; Raikwar SP; Iyer SS; Zaheer A
    J Alzheimers Dis; 2018; 66(3):1117-1129. PubMed ID: 30372685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice.
    Ou Z; Zhou Y; Wang L; Xue L; Zheng J; Chen L; Tong Q
    Mol Neurobiol; 2021 Apr; 58(4):1303-1311. PubMed ID: 33169332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
    Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
    Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of glia maturation factor expression prevents 1-methyl-4-phenylpyridinium (MPP⁺)-induced loss of mesencephalic dopaminergic neurons.
    Khan MM; Zaheer S; Nehman J; Zaheer A
    Neuroscience; 2014 Sep; 277():196-205. PubMed ID: 25016212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
    J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
    Qiao C; Zhang Q; Jiang Q; Zhang T; Chen M; Fan Y; Ding J; Lu M; Hu G
    J Neuroinflammation; 2018 Jul; 15(1):193. PubMed ID: 29966531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperoside suppresses NLRP3 inflammasome in Parkinson's disease via Pituitary Adenylate Cyclase-Activating Polypeptide.
    Wang K; Lu C; Wang T; Qiao C; Lu L; Wu D; Lu M; Chen R; Fan L; Tang J
    Neurochem Int; 2022 Jan; 152():105254. PubMed ID: 34883151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
    Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
    Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 Inhibits MPP
    Yao S; Li L; Sun X; Hua J; Zhang K; Hao L; Liu L; Shi D; Zhou H
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):478-492. PubMed ID: 31069623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
    Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
    Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macrophage migration inhibitory factor meditates MPP+/MPTP-induced NLRP3 inflammasome activation in microglia cells].
    Huang H; Gao Y; Nie K; Wang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):972-979. PubMed ID: 34308845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
    Gordon R; Albornoz EA; Christie DC; Langley MR; Kumar V; Mantovani S; Robertson AAB; Butler MS; Rowe DB; O'Neill LA; Kanthasamy AG; Schroder K; Cooper MA; Woodruff TM
    Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
    Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
    J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
    Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
    J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y
    J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.